Home2019-03-05T16:46:01+00:00
Loading...

The COLOSSUS Project

Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.

For more details about this innovative project and our aims see here.

Project Partners

The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.

Latest News

News from our Partners at INSERM

March 4th, 2019|

Congratulations to Dr Florent Petitprez who earned his PhD. Florent's PhD project was titled: Analyse intégrée et impact clinique des microenvironnements immunitaires et stromaux des tumeurs solides*. COLOSSUS is acknowledged in the PhD thesis. The research was [...]

COLOSSUS Winter 2019 newsletter is available

February 25th, 2019|

Read the latest project news in our Winter 2019 COLOSSUS newsletter. Get an update on the COLOSSUS translational trial and read the dissemination highlights too. In this edition, our 'Partner in the Spotlight" is Cancer Trials [...]

VIEW NEWS